COPD activates bitter taste receptors, the target of asthma treatment

Published Date: 17 Mar 2023

Germany: Activation of bitter taste receptors opens lung pathways, making them potential targets for the treatment of chronic lung diseases...

Read Full News

Latest News

Dupilumab Offers Broad Effectiveness for Severe Asthma

Real-world data show success in multiple components of clinical remission.

No Racial Differences Appear in Common COPD Scores

Results support the need for attention to social determinants of health and health system disparities.

COPD and Heart Disease Demand Integrated Clinical Care

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant's Experimental Lung Disease Drug Meets Goals in Mid-stage Study

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Shared Decision-Making in Pediatric Lung Care

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Advances in Care for Rare Pediatric Lung Diseases

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Todays Updates

Osimertinib's OS Benefit in Resected NSCLC Persists 8 Years

Even years after treatment ends, adjuvant osimertinib brings an overall survival benefit to patients with resected EGFR-mutated lung cancer.

Pelvic RT Tied to Longer Survival in Cervical Cancer

In patients with newly diagnosed stage IVB cervical cancer, adding definitive-dose pelvic radiotherapy to chemotherapy was associated with longer survival compared with chemotherapy alone.

New Data Put ADCs on the Map in Relapsed SCLC

Two B7-H3-directed antibody-drug conjugates substantially improve survival over topotecan among patients with relapsed small cell lung cancer — pointing to a potential new treatment class.

Real-World Liso-Cel Results in MCL Consistent With Trials

Two analyses of liso-cel CAR T-cell therapy in relapsed or refractory mantle cell lymphoma show response rates in the real-world setting similar to those seen in clinical trial populations.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

Antibiotic use in patients under hospice care is associated with an increased risk for mortality; for infectious hospice-qualifying conditions, antibiotic use is linked to extended survival.

Latest News

Real-world data show success in multiple components of clinical remission.

Results support the need for attention to social determinants of health and health system disparities.

Failing to look beyond spirometry in COPD costs lives. Experts at ERS 2026 present new clinical guidance to unify cardiovascular and respiratory management.

Roivant said on Tuesday its experimental drug met the main goals of a mid-stage study in patients ⁠with high blood pressure associated with a type of lung disease, sending...

Effective communication, empathy amid medical uncertainty, and structured transition plans improve pediatric pulmonary care and the transition to adult care.

Living with a rare lung condition can be especially challenging, but research into interogran cross talk and organoid models, and cross-border registry are improving outcomes.

News All Time

Nerve Stimulation for Sleep Apnea Linked to Some Long-Term Heart Benefits

But the higher risk of hypertension and cardiovascular events within 2 years was unexpected

Wildfire Smoke Kills Tens of Thousands Each Year. Here's How It Attacks the Body.

"It's a big giant toxic soup of particles and gases," expert says

FDA Greenlights Next-Generation ROS1 Inhibitor for Lung Cancer

Zidesamtinib is indicated for patients who received a prior ROS1 inhibitor

Reproductive Health Should Be Emphasized in Cystic Fibrosis Care, Foundation Says

Clinicians should initiate annual discussions

Novel Antifungal Shows Activity in Valley Fever

Three-quarters of patients had a clinical response in mid-stage study

CDC Suggests Threat of Mold-Associated Illnesses May Be Underappreciated

"It's kind of the first time we've had an estimate like this," the study's senior author says

FDA Approves First mRNA Flu Vaccine

Approval is for people 50 years or older

Dirty Air Worsens Rheumatoid Arthritis Outcomes, Study Shows

Small particulate matter seen as the main culprit

Senators Pan Trump Officials' Demand for Health Data as Condition for Lifesaving Aid

"These new demands set an alarming precedent," Democratic senators noted

Real-World Study Backs Mepolizumab in Rhinosinusitis With Nasal Polyps

— 20% of patients were on their way to remission

Overheard in Medicine: Pandemic Wounds Reopened

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Tenax Heart Drug Fails to Improve Walking Results in Study, Shares Plunge

Tenax Therapeutics said on Monday its experimental drug did not significantly improve how far patients could walk compared with ⁠placebo in a late-stage trial for a...

Ivacaftor Boosts Height and Lung Function in Cystic Fibrosis

Children and young adults with cystic fibrosis, especially those with severe CFTR variants, who receive ivacaftor have improved height and lung capacity than peers who do not receive ivacaftor.

Housing Aid Linked to Better NSCLC Survival

Housing assistance was associated with lower mortality among older adults with NSCLC, but the survival advantage was not explained by differences in guideline-concordant treatment.

More Bronchiectasis Patients Benefit From HEMT

Data from the US Bronchiectasis and NTM Research Registry show improvements in cough and exacerbations with highly effective modulator therapy.

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Integrating Evolving IO Strategies in Frontline mNSCLC Management

Recommended News For You

Smarter targeted radiotherapy just as effective for low-risk breast cancer and reduces risk of side effects

AI is useful in low-resource areas for triaging breast masses.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

Team finds broken 'brake' on cancer mutation machine.

Antitumor mRNA-based vaccines show potential against gastric cancer metastasis

Study suggests radiation therapy benefits misjudged when clinical factors alone guide breast cancer treatment

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Recommended Articles For You

Guidelines for Transfusion Threshold Assessment 

Hematopoietic Recovery Potential and Long-Term Survival: Mechanisms, Clinical Impact, and Emerging Directions 

Unveiling the Mystery of Epstein-Barr Virus: What We Know So Far 

Pediatric Bone-Marrow Niche Development: Mechanisms, Clinical Relevance, and Emerging Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS

2.

Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC

3.

Older Age Alone Does Not Limit Adagrasib Benefit in NSCLC

4.

Scientists develop scans that light up aggressive cancer tumors for better treatment

5.

Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals

1.

Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options

2.

Molecular Interaction Maps in Refractory Blood Disease: Mechanistic Insights and Clinical Applications

3.

All About Ferric Gluconate – The Best Source Of Iron For Anemia

4.

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice

5.

Spatially Targeted Intratumoral Therapeutics: Mechanisms, Clinical Applications, and Future Directions

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II

2.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective

3.

Recognizing the Signs of Anemia in Adults

4.

From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL

5.

Clinical Insights in Oncology

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot